You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Renal Cell Carcinoma

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

Active, not recruiting
  • Chronic Granulomatous Disease Transplant
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 21, 2023

Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Neoplasm
  • (no location specified)
Apr 24, 2023

Diffuse Large B Cell Lymphoma Trial (Pembrolizumab, Rituximab, Ifosfamide)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Headington, Oxford, United Kingdom
  • +1 more
Nov 2, 2022

Renal Cancer Metastatic Trial in Guangzhou (Combinations treatment)

Unknown status
  • Renal Cancer Metastatic
  • Combinations treatment
  • Guangzhou, Guangdong, China
    Cancer Center, Sun Yat-sen University
Nov 8, 2018

DLBCL, Grade 3b Follicular Lymphoma, Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial (biological, procedure, drug,

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • +6 more
  • Axicabtagene Ciloleucel
  • +10 more
  • (no location specified)
Jan 13, 2023

NSCLC, Solid Tumors, Programmed Cell Death-1 (PD1, PD-1) Trial (MK-2870, Pembrolizumab, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +4 more
  • MK-2870
  • +2 more
  • (no location specified)
Sep 15, 2023

Staphylococcal Bacteraemia Trial in Canada, United States (Cefazolin, Dalbavancin, Daptomycin)

Recruiting
  • Staphylococcal Bacteraemia
  • Birmingham, Alabama
  • +22 more
Jul 28, 2022

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell Trial in United Kingdom (ALETA-001)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • +4 more
  • Birmingham, United Kingdom
  • +5 more
Sep 18, 2023

Short Bowel Syndrome Trial in Worldwide (teduglutide)

Completed
Has Results
  • Short Bowel Syndrome
  • La Jolla, California
  • +22 more
Jun 3, 2021

Volume Overload Trial in Cleveland (Oral Sodium Chloride, Placebo)

Active, not recruiting
  • Volume Overload
  • Oral Sodium Chloride
  • Placebo
  • Cleveland, Ohio
    Cleveland Clinic
Oct 1, 2022

Gastric Cancer Trial in Qingdao (Chimeric antigen receptor T cell preparation targeting Claudin18.2)

Recruiting
  • Gastric Cancer
  • Chimeric antigen receptor T cell preparation targeting Claudin18.2
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
Jul 11, 2023

Sepsis, Acute Infection, Organ Failure Trial (Fisetin-dose 1, Fisetin-dose 2, Placebo)

Not yet recruiting
  • Sepsis
  • +2 more
  • Fisetin-dose 1
  • +2 more
  • (no location specified)
Feb 24, 2023

Transcatheter Aortic Valve Replacement Trial in Baltimore (Iodinated Contrast Agent (Omnipaque), Dual Energy CT)

Not yet recruiting
  • Transcatheter Aortic Valve Replacement
  • Iodinated Contrast Agent (Omnipaque)
  • Dual Energy CT
  • Baltimore, Maryland
    University of Maryland Medical Center
Feb 24, 2023

Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia

Recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2022

Renal Stone Trial in Cairo (percutaneous nephrolithotomy (supine position), percutaneous nephrolithotomy ( prone position))

Completed
  • Renal Stone
  • percutaneous nephrolithotomy (supine position)
  • percutaneous nephrolithotomy ( prone position)
  • Cairo, Egypt
    Ain Shams University hospital
Jul 13, 2022

Bladder Cancer Trial in United States (Apaziquone, Placebo, TURBT)

Completed
Has Results
  • Bladder Cancer
  • Anchorage, Alaska
  • +73 more
Mar 9, 2021

Chronic Kidney Failure in Children and Young Adults Trial (Dapagliflozin, Placebo)

Not yet recruiting
  • Chronic Kidney Failure in Children and Young Adults
  • (no location specified)
Jul 10, 2023

Colorectal Tumors Trial in Melbourne (CS-1008)

Completed
Has Results
  • Colorectal Neoplasms
  • Melbourne, Victoria, Australia
    Ludwig Institute Tumor Targeting Program, Austin Health
Oct 3, 2022

Cutaneous T-Cell Lymphoma, Graft Vs Host Disease, Graft Rejection Trial in Besançon (Samples collection)

Recruiting
  • Cutaneous T-Cell Lymphoma
  • +2 more
  • Samples collection
  • Besançon, France
    Centre Hospitalier Universitaire de Besançon
May 31, 2022

Advanced or Metastatic Solid Tumors Trial in Beijing (CD40 ligand expressing MSLN-CAR T cells, Albumin-bound paclitaxel,

Recruiting
  • Advanced or Metastatic Solid Tumors
  • CD40 ligand expressing MSLN-CAR T cells
  • +2 more
  • Beijing, Beijing, China
    Kaichao Feng
Jan 19, 2023

Adenoid Cystic Carcinoma Trial in Beijing (68Ga-PSMA, 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617)

Recruiting
  • Adenoid Cystic Carcinoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Mar 18, 2021

Myocardial Fibrosis Associated With Monocyte Phenotype in End

Withdrawn
  • Myocardial Fibrosis
  • +4 more
  • Cardiac MRI 1 - With Gadolinium Contrast
  • +4 more
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Sep 30, 2021

Ovarian Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Tumors Trial in Worldwide (biological, drug, other)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Pembrolizumab
  • +4 more
  • Phoenix, Arizona
  • +178 more
Jan 25, 2023

Ampullary Carcinoma Trial (Surufatinib+Toripalimab+AG)

Not yet recruiting
  • Ampullary Carcinoma
  • (no location specified)
Sep 29, 2023

Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia-2, High Grade Malignant Tumor Trial in

Completed
Has Results
  • Blasts 10 Percent or More of Bone Marrow Nucleated Cells
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 11, 2021